Status:
COMPLETED
Innovative "Scoring System" in Breast Cancer Post Neoadiuvant Chemotherapy
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Early Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Our aim is to create a Scoring System (SS) able of guaranteeing radical oncology by completely removing cancer and aesthetic outcomes in line with the needs or expectations of the patients that helps ...
Eligibility Criteria
Inclusion
- Patients undergoing neoadjuvant chemotherapy
- Surgery: Breast conservative surgery; Oncoplastic surgery type II; Conservative mastactomy (nipple sparing - NSM or skin sparing - SSM)
Exclusion
- lack of initial staging or restaging;
- previous or synchronous history of systemic malignant neoplasms.
- history of homo-or contralateral breast cancer.
- initial evidence of metastatic pathology or development of metastases during noeadjuvant chemotherapy (Stage IV)
- indication to modified radical mastectomy (MRM) without delayed reconstruction
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT05213403
Start Date
January 1 2016
End Date
December 31 2021
Last Update
January 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.